Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for emergence cough and postoperative sore throat in thyroidectomy
ChiCTR2600122891Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Post-extubation sore throat (POST), cough and thyroidectomy (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Postoperative sore throat severity, Incidence of postoperative sore throat and 1 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-extubation sore throat (POST)coughthyroidectomy
Beyond the preview
Go deeper on ChiCTR2600122891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122891.